Vir Biotechnology Inc.
VIR | NASDAQ
$10.88
+$0.28 (+2.64%)
At close: Sep 21, 2026, 4:00 PM ET
$11.31
+$0.43 (+3.95%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 68.56M | 74.21M | 86.18M | 1.62B | 1.1B | 67.25M |
Cost of Revenue | 11.71M | 478.65M | 572.83M | 620.97M | 513.87M | n/a |
Gross Profit | 56.85M | -404.44M | -486.65M | 994.83M | 581.54M | 67.25M |
Operating Income | -468.02M | -587.17M | -684.31M | 833.07M | 420.75M | -296.98M |
Interest Income | 40.24M | 71.81M | 86.99M | 28.09M | 439K | 2.84M |
Pretax Income | -437.77M | -523.11M | -628.19M | 754.28M | 549.8M | -298.61M |
Net Income | -437.99M | -521.96M | -615.06M | 515.84M | 528.58M | -298.67M |
Selling & General & Admin | 92.07M | n/a | n/a | n/a | n/a | 70.94M |
Research & Development | 432.8M | 506.5M | 579.72M | 474.65M | 448.01M | 302.41M |
Other Expenses | n/a | -323.77M | -382.06M | -312.89M | -287.21M | -9.12M |
Operating Expenses | 524.87M | 182.73M | 197.66M | 161.76M | 160.79M | 364.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 536.58M | 661.37M | 770.49M | 782.73M | 674.66M | 364.23M |
Income Tax Expense | 217K | -1.15M | -13.08M | 238.44M | 21.22M | 54K |
Shares Outstanding (Basic) | 138.52M | 136.25M | 134.13M | 132.61M | 129.88M | 119.16M |
Shares Outstanding (Diluted) | 138.52M | 136.25M | 134.13M | 134.81M | 133.44M | 119.16M |
EPS (Basic) | -3.16 | -3.83 | -4.59 | 3.89 | 4.07 | -2.51 |
EPS (Diluted) | -3.16 | -3.83 | -4.59 | 3.83 | 3.96 | -2.51 |
EBITDA | -426.09M | -508.91M | -641.64M | 761.06M | 555.61M | -291.54M |
EBIT | -437.77M | -523.47M | -661.09M | 754.28M | 549.8M | -296.98M |
Depreciation & Amortization | 11.68M | 14.56M | 19.45M | 6.78M | 5.81M | 5.44M |
Add to Watchlist
Select watchlists to add or remove VIR